Atacicpet, Sibeprenlimab Halt Decline in Kidney Function in IgA Nephropathy

(MedPage Today) -- DENVER -- Two IgA nephropathy drugs -- atacicept (Trutakna) and sibeprenlimab injection (Voyxact) -- showed they were able to slow kidney function decline in final phase III trial efficacy analyses. Atacicept and sibeprenlimab...